Patients with depression tend to demonstrate significantly elevated levels of various chemokines (CCL2, CXCL10), and pro-inflammatory cytokines, such as interleukin (IL)−1β, IL-6, and tumor necrosis factor (TNF) [26,27,28,29,30]. This evidence concerns the gene IL1B and depressive symptom measurement.